Communication of an Abnormal Metabolic Newborn Screening Result in the Netherlands: A Qualitative Exploratory Study of the General Practitioner’s Perspective
Abstract
1. Introduction
2. Materials and Methods
- Contact the GP who referred the child with an abnormal NBS result.
- Ask if the GP is willing to receive information about a study regarding the communication of an abnormal metabolic NBS result.
- Send the contact details from the GP to the researcher (SH) in case of the GP’s approval.
3. Results
3.1. Dealing with the Urgency of the Metabolic NBS Result
Dealing with the Urgency of the Metabolic NBS Result—Quotes |
---|
Sub-theme 1: Way of Performing the Conversation |
1a Participant 09: “I went there [to the parents’ home]. Because that was her [the pediatrician] advice, I had to examine the child, whether it wasn’t lethargic for example.” 1b Participant 12: “I didn’t know whether they would be home, so I first made a phone call, told them that the new born screening result was abnormal, and then I performed a home visit.” 1c Participant 08: “I wanted to perform a home visit until I found out that she [the mother] was a GP herself… …The less highly educated people are, the sooner I would perform a home visit. But it also costs extra time, and you do need to have that extra time in that moment.” |
Sub-theme 2: Logistical hurdles to perform the conversation |
2a Participant 07: “…all of a sudden you are confronted with this result in a busy day, and they immediately expect you to do something with it [the abnormal NBS result]… …In a hectic day where you are already doing so many things at once, getting a result like this on your plate is pretty hard.” |
2b Participant 08: “You are expected to immediately undertake action, all the while you also still have a completely different program running throughout the day… …I was in the middle of my outpatient clinic. So I felt urged to call the parents as quickly as possible with of course bad news. That felt very uncomfortable.” 2c Participant 03: “Ideally I would have performed a home visit. I think I would have done it [a home visit] if I wouldn’t have to pick up my child from daycare. If I would have had the time then I would have done it, but it just wasn’t possible.” |
Sub-theme 3: Estimation of the Urgency |
3a Participant 01: “I had no clue what kind of disease this was, and whether you had to undertake action immediately or not… Because that is also the question, do you have to see the child right now?… I think we were able to make a good decision on that, but that really was a decision made together [with the pediatrician].” |
3.2. The Role of the GP in the NBS Process
The Role of the GP in the NBS Process—Quotes |
---|
Sub-theme 1: The role of the GP |
1a Participant 01: “I’m just there for emotional support. And I can of course examine the child, which the pediatrician is not able to do at that moment… …My role in this case is being there for the parents I would say. |
1b Participant 02: “I could make a phone call for social support, but a clear explanation [of the IMD] is outside the scope of the GP.” |
1c Participant 08: “As a GP you are not part of the newborn screening process. The test is taken by someone else, the results are interpreted by someone else, and then I am the one who all of a sudden needs to make a referral and needs to tell the parents. Well, that feels strange to me.” 1d Participant 12: “What I find strange is that we do not organize these newborn screening tests, the results that come from these tests, we often don’t have a clue of what they mean, it is so rare that you can read into it, but the next time you will have forgotten about it again. So you are actually giving parents someone else’s information, you are the messenger of something you don’t really know the answer to. (…) And that might be what’s behind all of it, a bit of frustration. And then it [communicating the NBS result] is also something that you actually don’t know anything about and ‘you just have to do it’. Well, I don’t like that very much.” |
Sub-theme 2: Level of Experience with IMD |
2a Participant 01: “…I just gave the message that something was wrong, we don’t exactly know how and to what degree. It is important that we are going to figure it out as soon as possible, and that we are going to call the pediatrician right now. …We should not expect the GP to give that specific information [about the IMD].” |
2b Participant 09: “…That is also what I told the parents, that it really was my first time. But then you also feel a little bit of a nitwit, it feels a bit lame [having little experience with the IMD], and I can imagine that some parents say ‘well why are you the one coming to tell me then’, who actually are you, so to speak.” |
Sub-theme 3: Satisfaction with Conversation |
3a Participant 01: [Did you miss something in the conversation? Would there be anything to improve?] “I wouldn’t know. This [abnormal NBS result] gives such an incredible amount of stress about the health of your newborn, it is dramatic for parents, if you can relieve that even for a little by answering questions quickly, I think that worked out very well. If it is always arranged in this [performing the conversation with the pediatrician on speaker] way, then I think that would be beautiful.” 3b Participant 06 (on paper): “Not okay due to the wrong timing and bad logistics.” 3c Participant 09: “Well, I thought it [the conversation with parents] went very well, but I was quite nervous to have to go to the parents. I have been a GP for almost nine years, and I did not really know how this goes. So it took me by surprise.” 3d Participant 12: [Do you feel like you were able to inform the parents sufficiently?] “No, I actually don’t… Because of just being the messenger, and I don’t really think that that is my role as a GP.” |
3.3. The Current Organization of NBS in the Netherlands
The Current Organization of NBS in the Netherlands—Quotes |
---|
Sub-theme 1: Collaboration with the Medical Advisor of the RIVM and Pediatrician |
1a Participant 03: “I found that very pleasant, that you had very direct communication. I immediately received the right phone numbers and names, so that you don’t have to figure it all out yourself.” 1b Participant 04 (on paper): [What did you think of the cooperation with the medical advisor of the RIVM and the pediatrician?] “All very pleasant and skilled.” 1c Participant 07: “with the pediatrician fine, she supported me with what she could, I think. With the RIVM, it feels a little bit like passing work off to someone else, I don’t really know how to describe it, like here you have the phone call and the result and good luck.” |
Sub-theme 2: Role of RIVM |
2a Participant 03: “It was very nice that she had already taken action, the referral to the pediatrician was already arranged, an appointment with the pediatrician was already made, and she gave me the phone number of the pediatrician to discuss briefly before the conversation with parents. That was all very pleasant, that I didn’t have to enter the conversation completely blank. I, of course, had no idea what it [the IMD] was, so she [the medical advisor of the RIVM] already explained a lot and advised me to call the pediatrician for more explanation.” |
Sub-theme 3: Role of Pediatrician |
3a Participant 12: [Did you consider calling the pediatrician during the conversation with parents?] “The pediatrician suggested that, but I declined, saying that I simply don’t have the time or space for it.” |
3b Participant 01: “I first called the pediatrician to discuss what I should pay attention to [during the home visit]. The pediatrician knew about the abnormal NBS result so could very well explain to me what I should look for, then I went there and agreed to call the pediatrician again during the conversation with parents. That went very well. …There are so many questions that I can’t answer during a conversation like this. …In this way [with the pediatrician on speaker] you can answer the questions and make a good first estimation of the situation.” 3c Participant 03: “The pediatrician gave me a bit of reassurance. I thought, a metabolic disease can be quite anxious, it could be very serious. But the pediatrician indicated that the metabolic disease that the girl possibly had was very good to live with, with for example a strict diet. That gave me some reassurance, and then you are able to enter the conversation with parents differently.” |
Sub-theme 4: Information Provision |
4a Participant 04 (on paper): “That was nice, since it isn’t about everyday medical information (for a GP), it is nice to have information and some explanation about the disease, but also about practical things like hospital appointments, what to take into account, etc.” 4b Participant 07: [What did you think of the information provided in the disease-specific information leaflet?] “Well it actually only included information about the specific patient and about what disease was found, no other medical content. It was very brief…. For now [parents already had a child with the same IMD] it was okay, but if it would have been the first time that I would have to confront parents with this news, it really would not have been enough for me. I would not be able to answer questions from parents sufficiently” 4c Participant 12: [What did you think of the information provision? Was it sufficient?] “Actually, no, I read something of which I have never heard, maybe during my study but that is far far away in my memory. No, for me it is new, it’s so specialized, we, as GPs, just don’t know that.” |
3.4. Evaluating Roles and Responsibilities in Communicating Abnormal Metabolic NBS Results
Evaluating Roles and Responsibilities in Communicating Abnormal Metabolic NBS Results—Quotes |
---|
Sub-theme 1: Involvement of GP |
1a Participant 07: “I also strongly question whether these kind of abnormal NBS results should be directed to us. I do understand that we are part of a specific branch within medicine with a broad range of responsibilities, but these [IMDs] are such niche topics that we encounter so rarely. I think even a general pediatrician would struggle to provide clear information about these cases, so you really need someone with specialized knowledge who can convey clear information to parents.” 1b Participant 08: “It would be best if the RIVM also contacts the parents, also because the pediatrician didn’t necessarily needed a referral. If it would be handled by the RIVM and we would stay out of it.” 1c Participant 11: “We thought about it before, what makes sense? We do not perform the newborn screening and also do not do the follow up. On the other hand, we do follow up the parents, and you do know the parents. So to me it makes sense that it is arranged this way, but the first time we came in touch with it [communicating an abnormal NBS result], I thought, ‘hold on’, how does this work and does this make sense.” |
Sub-theme 2: Shared Responsibility |
2a Participant 04 (on paper): “I can imagine that in some situations the metabolic pediatrician directly contacts the parents. It could, for example, be an extra question when performing the newborn screening test: “Would you like to be contacted via phone in case of an abnormal NBS result, or would you rather be contact by your own GP about the abnormal NBS result?’. But again, as a GP, I want to be informed as soon as possible about this information!” 2b Participant 07: “I wonder that if the RIVM already had contact with the pediatrician, if they shouldn’t let the pediatrician contact the parents. Then a lot of questions can be answered straight away, they can give a lot more clarity about what is going on and what to expect.” 2c Participant 09: “I’m not really sure, but I do wonder whether it really has to be done by the GP. I think it might be more suitable for the youth health physician or the Public Health Service doctor. After all, the child is already well known at the Child Health Clinic * and the Public Health Service doctor. They just had the two-week screening. Meanwhile, they don’t typically come to me.” 2d Participant 10: “It is of course a public health issue, so you could also imagine the Public Health Service doctor taking it on. Perhaps that could provide a shorter line of communication. That said, there is a shortage of Public Health Physicians, so in that sense I’m not sure if it would be practical. But I do think it’s an interesting question, maybe it really is something for the Public Health Physician?” |
4. Discussion
5. Limitations
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
PKU | Phenylketonuria |
IMD | Inherited Metabolic Diseases |
RIVM | National Institute for Public Health and the Environment |
Phe | Phenylalanine |
NBS | Newborn Screening |
GP | General Practitioner |
References
- De Historie van de Hielprikscreening—Draaiboek Hielprikscreening RIVM. Available online: https://draaiboekhielprikscreening.rivm.nl/over-nhs/de-historie-van-de-hielprikscreening (accessed on 3 July 2025).
- Clinical Picture—Prenatale En Neonatale Screeningen. Available online: https://www.pns.nl/node/7171 (accessed on 30 October 2023).
- Loeber, J.G.; Burgard, P.; Cornel, M.C.; Rigter, T.; Weinreich, S.S.; Rupp, K.; Hoffmann, G.F.; Vittozzi, L. Newborn Screening Programmes in Europe; Arguments and Efforts Regarding Harmonization. Part 1—From Blood Spot to Screening Result. J. Inherit. Metab. Dis. 2012, 35, 603–611. [Google Scholar] [CrossRef]
- Organisation—Prenatale En Neonatale Screeningen. Available online: https://www.pns.nl/hielprik/professionals/organisatie (accessed on 30 October 2023).
- Ulph, F.; Cullinan, T.; Qureshi, N.; Kai, J. Parents’ Responses to Receiving Sickle Cell or Cystic Fibrosis Carrier Results for Their Child Following Newborn Screening. Eur. J. Hum. Genet. 2015, 23, 459. [Google Scholar] [CrossRef]
- Buchbinder, M.; Timmermans, S. Newborn Screening for Metabolic Disorders: Parental Perceptions of the Initial Communication of Results. Clin. Pediatr. 2012, 51, 739–744. [Google Scholar] [CrossRef]
- van den Heuvel, L.M.; van der Pal, S.M.; Verschoof-Puite, R.K.; Klapwijk, J.E.; Elsinghorst, E.; Dekkers, E.; van der Ploeg, C.P.B.; Henneman, L. Psychosocial Impact of a True-Positive, False-Positive, or Inconclusive Newborn Bloodspot Screening Result: A Questionnaire Study Among Parents. Int. J. Neonatal Screen. 2024, 10, 18. [Google Scholar] [CrossRef] [PubMed]
- Chudleigh, J.; Chinnery, H.; Bonham, J.R.; Olander, E.; Moody, L.; Simpson, A.; Morris, S.; Ulph, F.; Bryon, M.; Southern, K. Qualitative Exploration of Health Professionals’ Experiences of Communicating Positive Newborn Bloodspot Screening Results for Nine Conditions in England. BMJ Open 2020, 10, e037081. [Google Scholar] [CrossRef]
- Chudleigh, J.; Holder, P.; Moody, L.; Simpson, A.; Southern, K.; Morris, S.; Fusco, F.; Ulph, F.; Bryon, M.; Bonham, J.R.; et al. Process Evaluation of Co-Designed Interventions to Improve Communication of Positive Newborn Bloodspot Screening Results. BMJ Open 2021, 11, e050773. [Google Scholar] [CrossRef]
- Haitjema, S.; Lubout, C.M.A.; Zijlstra, J.H.M.; Wolffenbuttel, B.H.R.; van Spronsen, F.J. Communication of an Abnormal Metabolic New-Born Screening Result in The Netherlands: The Parental Perspective. Nutrients 2022, 14, 3961. [Google Scholar] [CrossRef] [PubMed]
- Braun, V.; Clarke, V. Using Thematic Analysis in Psychology. Qual. Res. Psychol. 2006, 3, 77–101. [Google Scholar] [CrossRef]
- Walker, J.L. The Use of Saturation in Qualitative Research. Can. J. Cardiovasc. Nurs. 2012, 22, 37–46. [Google Scholar]
- Bush, L.W.; Levy, H.L. Past as Prologue: Predicting Potential Psychosocial-Ethical Burdens of Positive Newborn Screens as Conditions Propagate. Int. J. Neonatal Screen. 2024, 10, 12. [Google Scholar] [CrossRef]
- Chudleigh, J.; Buckingham, S.; Dignan, J.; O’Driscoll, S.; Johnson, K.; Rees, D.; Wyatt, H.; Metcalfe, A. Parents’ Experiences of Receiving the Initial Positive Newborn Screening (NBS) Result for Cystic Fibrosis and Sickle Cell Disease. J. Genet. Couns. 2016, 25, 1215–1226. [Google Scholar] [CrossRef]
- Collins, J.L.; La Pean, A.; O’Tool, F.; Eskra, K.L.; Roedl, S.J.; Tluczek, A.; Farrell, M.H. Factors That Influence Parents’ Experiences with Results Disclosure After Newborn Screening Identifies Genetic Carrier Status for Cystic Fibrosis or Sickle Cell Hemoglobinopathy. Patient Educ. Couns. 2013, 90, 378–385. [Google Scholar] [CrossRef]
- Blom, M.; Bredius, R.G.M.; Jansen, M.E.; Weijman, G.; Kemper, E.A.; Vermont, C.L.; Hollink, I.H.I.M.; Dik, W.A.; van Montfrans, J.M.; van Gijn, M.E.; et al. Parents’ Perspectives and Societal Acceptance of Implementation of Newborn Screening for SCID in the Netherlands. J. Clin. Immunol. 2021, 41, 99–108. [Google Scholar] [CrossRef] [PubMed]
- Rueegg, C.S.; Barben, J.; Hafen, G.M.; Moeller, A.; Jurca, M.; Fingerhut, R.; Kuehni, C.E. Newborn Screening for Cystic Fibrosis —The Parent Perspective. J. Cyst. Fibros. 2016, 15, 443–451. [Google Scholar] [CrossRef] [PubMed]
- Finan, C.; Nasr, S.Z.; Rothwell, E.; Tarini, B.A. Primary Care Providers’ Experiences Notifying Parents of Cystic Fibrosis Newborn Screening Results. Clin. Pediatr. 2015, 54, 67–75. [Google Scholar] [CrossRef] [PubMed]
- Hayeems, R.Z.; Miller, F.A.; Barg, C.J.; Bombard, Y.; Chakraborty, P.; Potter, B.K.; Patton, S.; Bytautas, J.P.; Tam, K.; Taylor, L.; et al. Primary Care Providers’ Role in Newborn Screening Result Notification for Cystic Fibrosis. Can. Fam. Physician 2021, 67, 439–448. [Google Scholar] [CrossRef]
- Di Ciommo, V.; Forcella, E.; Cotugno, G. Living with Phenylketonuria from the Point of View of Children, Adolescents, and Young Adults: A Qualitative Study. Behav. Pediatr. 2012, 33, 7. [Google Scholar] [CrossRef]
- Vockley, J.; Andersson, H.C.; Antshel, K.M.; Braverman, N.E.; Burton, B.K.; Frazier, D.M.; Mitchell, J.; Smith, W.E.; Thompson, B.H.; Berry, S.A. Phenylalanine Hydroxylase Deficiency: Diagnosis and Management Guideline. Genet. Med. 2014, 16, 188–200. [Google Scholar] [CrossRef]
- UK Health Security Agency, GOV.UK. A Laboratory Guide to Newborn Blood Spot Screening for Inherited Metabolic Diseases. Available online: https://www.gov.uk/government/publications/newborn-blood-spot-screening-laboratory-guide-for-imds/a-laboratory-guide-to-newborn-blood-spot-screening-for-inherited-metabolic-diseases (accessed on 3 July 2025).
- Chudleigh, J.; Ren, C.L.; Barben, J.; Southern, K.W. International Approaches for Delivery of Positive Newborn Bloodspot Screening Results for CF. J. Cyst. Fibros. 2019, 18, 614–621. [Google Scholar] [CrossRef]
- Burgard, P.; Rupp, K.; Lindner, M.; Haege, G.; Rigter, T.; Weinreich, S.S.; Loeber, J.G.; Taruscio, D.; Vittozzi, L.; Cornel, M.C.; et al. Newborn Screening Programmes in Europe; Arguments and Efforts Regarding Harmonization. Part 2—From Screening Laboratory Results to Treatment, Follow-Up and Quality Assurance. J. Inherit. Metab. Dis. 2012, 35, 613–625. [Google Scholar] [CrossRef]
- van der Horst, H.; de Wit, N. Redefining the Core Values and Tasks of GPs in the Netherlands (Woudschoten 2019). Br. J. Gen. Pract. 2019, 70, 38. [Google Scholar] [CrossRef] [PubMed]
- Damoiseaux, R.A.; Bindels, P.J. Transferring Care from Secondary to Primary Health Services; Time for Action. Ned. Tijdschr. Geneeskd. 2014, 158, A7532. (In Dutch) [Google Scholar] [PubMed]
- Lawrence, W. Neuman Social Research Methods: Qualitative and Quantitative Approaches, 7th ed.; Allyn & Bacon: Boston, MA, USA, 2011. [Google Scholar]
- O’Connor, C.; Joffe, H. Intercoder Reliability in Qualitative Research: Debates and Practical Guidelines. Int. J. Qual. Methods 2020, 19, 1609406919899220. [Google Scholar] [CrossRef]
- Braun, V.; Clarke, V. Thematic Analysis: A Practical Guide; SAGE: Newcastle, UK, 2021. [Google Scholar]
Healthcare Provider | The Process of Communication and Referral | Considerations in Choosing Various Routes for Communicating Abnormal NBS Results |
---|---|---|
General Practitioner * | Calls parents or performs home visit **, informs them of positive NBS result, referral to metabolic pediatrician. | Strengths: Is a familiar face to the family. Possibility to perform home visit and examine the child. Limitations: Parents will not receive detailed information before reaching the metabolic pediatrician. |
Medical Advisor from RIVM | Calls parents, informs them of positive NBS result, referral to metabolic pediatrician. | Strengths: Might be quicker than communication by the GP due to fewer logistical hurdles. Limitations: Not possible to examine the child. If parents cannot be reached by telephone or there is doubt on clinical severity, then another healthcare professional might still need to perform a home visit. |
Metabolic Pediatrician | Calls parents, informs them of positive NBS result, invites them for diagnostic evaluation. | Might be feasible if the child is seen on the same day. Is being done in Switzerland in cases of a positive CF result [17]. Strengths: Parents will receive accurate information right away, might reduce parental anxiety. Limitations: Not possible to examine the child. If parents cannot be reached by telephone, then another healthcare professional might still need to perform a home visit. |
Youth Healthcare Physician | Calls parents, might be able to perform home visit *, referral to metabolic pediatrician. | Strengths: Might be able to perform home visit and examine the child. Limitations: Is not used to see acutely ill patients. Parents will not receive detailed information before reaching the metabolic pediatrician. |
Specialized nurse | Calls parents, informs them of positive NBS result, invites them for diagnostic evaluation. | Is currently being done in the UK for CF [23]. Strengths: Parents will receive accurate information right away. Might reduce parental anxiety. Limitations: Not possible to examine the child. If parents cannot be reached by telephone, then another healthcare professional might still need to perform a home visit. |
Midwife | Can communicate result to parents during home visit *, referral to metabolic pediatrician. | Is being done in New Zealand, where midwives who are responsible for the care of the mother and child communicates the NBS result for CF [23]. Strengths: Is a familiar face to the family. Will be able to examine the child. Limitations: Parents will not receive detailed information before reaching the metabolic pediatrician. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Published by MDPI on behalf of the International Society for Neonatal Screening. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Haitjema, S.; Lubout, C.M.A.; Zijlstra, J.H.M.; Verschoof-Puite, R.K.; van Spronsen, F.J. Communication of an Abnormal Metabolic Newborn Screening Result in the Netherlands: A Qualitative Exploratory Study of the General Practitioner’s Perspective. Int. J. Neonatal Screen. 2025, 11, 62. https://doi.org/10.3390/ijns11030062
Haitjema S, Lubout CMA, Zijlstra JHM, Verschoof-Puite RK, van Spronsen FJ. Communication of an Abnormal Metabolic Newborn Screening Result in the Netherlands: A Qualitative Exploratory Study of the General Practitioner’s Perspective. International Journal of Neonatal Screening. 2025; 11(3):62. https://doi.org/10.3390/ijns11030062
Chicago/Turabian StyleHaitjema, Sietske, Charlotte M. A. Lubout, Justine H. M. Zijlstra, Rendelien K. Verschoof-Puite, and Francjan J. van Spronsen. 2025. "Communication of an Abnormal Metabolic Newborn Screening Result in the Netherlands: A Qualitative Exploratory Study of the General Practitioner’s Perspective" International Journal of Neonatal Screening 11, no. 3: 62. https://doi.org/10.3390/ijns11030062
APA StyleHaitjema, S., Lubout, C. M. A., Zijlstra, J. H. M., Verschoof-Puite, R. K., & van Spronsen, F. J. (2025). Communication of an Abnormal Metabolic Newborn Screening Result in the Netherlands: A Qualitative Exploratory Study of the General Practitioner’s Perspective. International Journal of Neonatal Screening, 11(3), 62. https://doi.org/10.3390/ijns11030062